1-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-1H-pyrazole, 97%, 1g

8-(3-iodophenyl)-8-oxooctanenitrile, 97.0%, 1g

2-(5-PHENYL-4-(PYRIDIN-4-YL)-1H-1,2,3-TRIAZOL-1-YL)-N-(5-PHENYLPYRIDIN-2-YL)ACETAMIDE, 95%, 10mg

5-Formyl-2-furancarboxylic acid, 98.0%, 5g

Sodium iodide, min. 99.5%, pa, ACS, 100 g, plastic packaging.

ethyl 8-oxo-8-phenyloctanoate, 97.0%, 1g

2-(4-Ethylcyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Tris(hydroxymethyl)aminomethane Acetate>99.0%(T)25g

3-Amino-6-iodopyrazine-2-carboxylic acid methyl ester, 95.0%, 100mg

4-Methoxy-2,6-dimethylphenylboronic Acid (contains varying amounts of Anhydride)1g

tert-Butyl (2S,5S)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 98%, 250mg

(3S)-8-fLuoro-1-methyl-3-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,4(1h,3h)-quinazolinedione, 98%, 250mg

2-Fluoro-4-(methylsulfonyl)aniline, 99.0%, 100g